Research and Markets: Amgen Partnering Guide 2008: An Insight into the Partnering...

Research and Markets: Amgen Partnering Guide 2008: An Insight into the Partnering Interests and Activities of one of the Worlds Leading Biopharma Companies

DUBLIN, Ireland--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/research/4b2952/amgen_partnering_g)
has announced the addition of the "Amgen Partnering Guide 2008"
company profile to their offering. This report provides all the
information you require to better understand Amgen and its partnering
interests and activities over the past five years.

One of the key aspects of partnering is finding those companies
that are potential partners for the development and commercialization
of the next generation of therapies as developed by innovative
biopharma R&D companies. A lot of resources are spent on finding
partners, identifying their interests and making contact to initiate
discussions.

Using this report, dealmakers will effectively and efficiently
determine the suitability of Amgen as a prospective partner, their
business development objectives, interests and recent partnering
activity, key partnering contacts, and partnering contract documents
signed with their recent partners. The report provides a firm basis
for initial due diligence into Amgen as a prospective partner company.

-0-
*T
Key benefits:

- Detailed company profile of the company
- In-depth marketed and pipeline product activity for the company
- Partnering interests and therapy focus revealed
- Partnering activity since 2000 - number of deals per year
- Partnering activity for 2005-2008:
Activity by deal type
Activity by phase of development
Activity by therapeutic area
- List of recent partner companies
- Comprehensive access to actual contracts entered into by the company
and its partners(1)
- Insight into the terms included in a partnering agreement
- Understand the key deal terms the company has agreed in previous
deals
- Undertake due diligence to assess suitability of your proposed deal
terms for partner companies
(1) Subject to being published via regulatory requirements of the
Securities Exchange Commission.

Report scope:
Amgen Partnering Guide 2008 is intended to provide the reader with an
in-depth understanding of the partnering activities and interests of
the company, enabling the effective assessment and selection of
partners of choice, based on the latest knowledge of a company's
approach to partnering.

Amgen Partnering Guide 2008 includes:
- Detailed company profile including:
- Full contact details
- Business developer contact details including name, title, email and
telephone (where available)
- Marketed indications
- Pipeline indications
- Partnering interests and indications
- Partnering activity since 2000
- Current partner companies since 2005
- Partnering activity since 2005 by:
Deal type
Stage of development
Therapy area
- Numerous charts showing the dealmaking activity of the company since
2005
- The tools to enable effective and efficient preparation for
partnering negotiation with the company
- Listing of contract documents between the company and its partners
- The leading M&A and partnering deals by value 2005-8
- Most active M&A and partnering dealmakers 2005-8

Key Topics Covered:

Chapter 1 - Introduction
Chapter 2 - Bigpharma - The Top 50
Chapter 3 - Most active bigpharma dealmakers
Chapter 4 - Top bigpharma deals - 2000-7
Chapter 5 - Submitting Opportunities to Bigpharma such as Amgen
Chapter 6 - Forthcoming bigpharma partnering events
Chapter 7 - Amgen - therapy locator
Chapter 8 - Bigpharma Company Profiles
*T

For more information visit
http://www.researchandmarkets.com/research/4b2952/amgen_partnering_g.

Research and Markets Ltd.
Laura Wood
Senior Manager
press@researchandmarkets.com
Fax from USA: 646-607-1907
Fax from rest of the world: +353-1-481-1716

Copyright Business Wire 2008